← Eichor
Condition: Opiates Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Opiates

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
Phase N/A · 1 location(s) · University Hospital, Limoges · NCT05361603Clinical Features Associated With Restless Legs Syndrome.
Phase N/A · 1 location(s) · University Hospital, Montpellier · NCT05044520Open-label Placebo for Pain Management in Adolescents and Young Adults Undergoing Bernese Periacetabular Osteotomy
NA · 1 location(s) · University of California, San Francisco · NCT07373210Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder
NA · 1 location(s) · Payel Roy · NCT07079826A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
Phase 3 · 1 location(s) · University of California, San Francisco · NCT05010148Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
NA · 1 location(s) · University of Pittsburgh · NCT06806163Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage
Phase 2 · 1 location(s) · The University of Texas Medical Branch, Galveston · NCT07294118Neuroimaging of Opioid Phase (OPAL)
NA · 1 location(s) · Duke University · NCT05905419Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use
Phase 2 · 1 location(s) · University of Pennsylvania · NCT06379984MethaLoad Dose-Finding Study
Phase 1 · 1 location(s) · University of Pennsylvania · NCT06877858Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal
Phase 2 · 2 location(s) · University of Pennsylvania · NCT05995535Virtual Reality As Adjunct Therapy for Vaso-Occlusive Pain
NA · 1 location(s) · Louisiana State University Health Sciences Center in New Orl · NCT06773715UnityPhilly Response App for Overdose Reversal
NA · 1 location(s) · Drexel University · NCT06466005Focused Ultrasound for the Complex Patient
NA · 1 location(s) · Washington D.C. Veterans Affairs Medical Center · NCT06453109GLP-1R Agonist Treatment for Opioid Use Disorder
Phase 2 · 4 location(s) · Milton S. Hershey Medical Center · NCT06548490Young Houston Emergency Opioid Engagement System
Phase 4 · 1 location(s) · The University of Texas Health Science Center, Houston · NCT04811014Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data
NA · 1 location(s) · University of Washington · NCT06768814A Bundled Intervention
Phase 1/Phase 2 · 1 location(s) · University of Alabama at Birmingham · NCT06593093Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone
Phase 1 · 3 location(s) · Atea Pharmaceuticals, Inc. · NCT07314346Ketorolac at Lower Doses for Analgesic Pain Control in ICU: A Pilot Feasibility Study
Phase 3 · 1 location(s) · University of Alberta · NCT06819956A Model to Save Lives Through a Volunteer First Responder Service Providing Antidote Treatment in Opioid Overdose
NA · 1 location(s) · Region Skane · NCT07079241Opioid Drug Interaction Study
Phase 1/Phase 2 · 1 location(s) · Shanna Babalonis, PhD · NCT06757140Smartphones for Opiate Addiction Recovery
Phase 3 · 2 location(s) · NYU Langone Health · NCT05033028Removing Barriers: Community Partnering for Innovative Solutions to the Opioid Crisis
NA · 2 location(s) · University of Michigan · NCT05665179
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.